simvastatin has been researched along with Primary Graft Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abo-Ramadan, U; Keränen, MA; Koli, K; Krebs, R; Lemström, KB; Neuvonen, PJ; Nykänen, AI; Syrjälä, S; Tikkanen, JM; Tuuminen, R | 1 |
| Lemström, KB; Nykänen, AI; Tuuminen, R | 1 |
1 review(s) available for simvastatin and Primary Graft Dysfunction
| Article | Year |
|---|---|
Donor simvastatin treatment and cardiac allograft ischemia/reperfusion injury.
Topics: Animals; Endothelial Cells; Graft Survival; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Microvessels; Myocardial Reperfusion Injury; Pericytes; Primary Graft Dysfunction; Simvastatin; Tissue Donors; Treatment Outcome | 2013 |
1 other study(ies) available for simvastatin and Primary Graft Dysfunction
| Article | Year |
|---|---|
Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection.
Topics: Animals; Endothelial Cells; Endothelin-1; Enzyme Inhibitors; Gap Junctions; Graft Rejection; Heart Transplantation; Heme Oxygenase-1; Hypoxia-Inducible Factor 1, alpha Subunit; Major Histocompatibility Complex; Male; Microvessels; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; No-Reflow Phenomenon; Polyisoprenyl Phosphates; Primary Graft Dysfunction; Rats; Rats, Inbred WF; Reperfusion Injury; rho-Associated Kinases; Simvastatin | 2011 |